logo
logo

Medincell Receives €4 Million In Funding From Bpifrance And Within The Framework Of The French Recovery Plan (Plan France Relance)

Medincell Receives €4 Million In Funding From Bpifrance And Within The Framework Of The French Recovery Plan (Plan France Relance)

12/01/21, 4:56 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/FR.svgmontpellier
Money raised
€4 million
Round Type
seed
Regulatory News:

Company Info

Company
Medin Cell
Location
montpellier, occitania, france
Additional Info
MedinCell is a clinical stage pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas by combining its proprietary BEPO® technology with active ingredients already known and marketed. Through the controlled and extended release of the active pharmaceutical ingredient, MedinCell makes medical treatments more efficient, particularly thanks to improved compliance, i.e. compliance with medical prescriptions, and to a significant reduction in the quantity of medication required as part of a one-off or chronic treatment. The BEPO® technology makes it possible to control and guarantee the regular delivery of a drug at the optimal therapeutic dose for several days, weeks or months starting from the subcutaneous or local injection of a simple deposit of a few millimeters, fully bioresorbable. Based in Montpellier, MedinCell currently employs more than 140 people representing over 25 different nationalities. www.medincell.com

Related People